Skip to main content
Caplight Logo









Pictor Labs

Pictor Labs

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.pictorlabs.ai/

Last Round

Series B

Extension

Jan 15, 2025

Total Funding Raised

$48.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pictor Labs is a digital pathology company that develops an AI-powered virtual staining platform for histopathology and clinical research.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Computer Vision, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

virtual stainingdigital pathologyAI stainingAI pathologycomputational pathologyimage-to-image translationspatial analyticsdeep learningLDTlab-developed testpathology workflowon-prem AIcancer diagnosticstissue imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pictor Labs Comparables

Compare Pictor Labs with similar companies based on industry and business-model similarity.

Pictor Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViewsML
87%
AIxMed, Inc.
80%
PathScience
77%

Pictor Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 15, 2025
Series BSep 18, 2024
Series ADec 1, 2022
SeedSep 23, 2020

Key People

Founding team and executive leadership

William Costello Medici

COO CMO COS

Executive Team

Pictor Labs Investors

Notable investors and investment history

Pictor Labs investors
InvestorRounds
M VenturesSeries B, Series A
Koç HoldingSeries A
M VenturesSeries B Extension, Series B, Series A
Insight PartnersSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Grew 16% QoQ, from 38 to 44 employees.

  • Jul 22, 2026

    Grew 17% QoQ, from 36 to 42 employees.

Pictor Labs Filings

Explore SEC and related filing metadata, where available.

Pictor Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pictor Labs's valuation, stock price, and market status.

Is Pictor Labs a public or private company?

Pictor Labs is a private company.

What is the current stock price of Pictor Labs?

Pictor Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Pictor Labs worth (valuation)?

Valuation information for Pictor Labs is not publicly available.

Can I buy Pictor Labs stock?

Pictor Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pictor Labs's last funding round?

Pictor Labs's most recent funding round was Series B Extension on January 15, 2025.

Who are the main investors in Pictor Labs?

Key investors in Pictor Labs include Koç Holding, M Ventures, Insight Partners.

Will Pictor Labs IPO soon?

No public IPO plans have been announced for Pictor Labs.

How can I track Pictor Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pictor Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range35
Year Founded2019
Last FundingJan 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?